| 000 | 01743 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517163052.0 | ||
| 264 | 0 | _c20171009 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1558-8238 | ||
| 024 | 7 |
_a10.1172/JCI92707 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWoodley, David T | |
| 245 | 0 | 0 |
_aGentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. _h[electronic resource] |
| 260 |
_bThe Journal of clinical investigation _cAug 2017 |
||
| 300 |
_a3028-3038 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAutoantibodies _xchemistry |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCodon, Nonsense |
| 650 | 0 | 4 |
_aCollagen Type VII _xgenetics |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEpidermolysis Bullosa Dystrophica _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenes, Recessive |
| 650 | 0 | 4 |
_aGentamicins _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intradermal |
| 650 | 0 | 4 |
_aKeratinocytes _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPatient Safety |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aProtein Synthesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aWound Healing |
| 700 | 1 | _aCogan, Jon | |
| 700 | 1 | _aHou, Yingping | |
| 700 | 1 | _aLyu, Chao | |
| 700 | 1 | _aMarinkovich, M Peter | |
| 700 | 1 | _aKeene, Douglas | |
| 700 | 1 | _aChen, Mei | |
| 773 | 0 |
_tThe Journal of clinical investigation _gvol. 127 _gno. 8 _gp. 3028-3038 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI92707 _zAvailable from publisher's website |
| 999 |
_c27352452 _d27352452 |
||